Age (y) | Responders (n = 50) | Non-responders (n = 52) | Difference |
---|---|---|---|
Mean (standard deviation) | 50 (12) | 52 (12) | Â |
Range | 23 - 68 | 19 - 69 | Â |
T-test | Â | Â | p = 0.90 |
Sex, n (%) | Â | Â | Â |
Male | 23 (46) | 21 (40) | Â |
Female | 27 (54) | 31 (60) | Â |
Chi-square test | Â | Â | p = 0.57 |
Diagnosis, n(%) | Â | Â | Â |
Solid tumors | 19 (38) | 34 (65) | Â |
Ovarian cancer | 2 (4) | 3 (9) | Â |
Breast cancer | 4 (8) | 8 (24) | Â |
Colorectal cancer | 3 (6) | 9 (26) | Â |
Cervical cancer | 7 (14) | 6 (18) | Â |
Other | 3 (6) | 8 (24) | Â |
Hematologic malignancies | 31 (62) | 18 (35) | Â |
Multiple myeloma | 5 (10) | 3 (17) | Â |
Non-Hodgkin's lymphoma | 19 (38) | 8 (44) | Â |
Hodgkin's lymphoma | 7 (14) | 7 (39) | Â |
Chi-square test | Â | Â | p = 0.11 |
Treatment, n (%) | Â | Â | Â |
Chemotherapy | 50 (100) | Â | Â |
+ Autologous Stem Cell Transplantation | 15 (30) | Â | Â |
+ Radiotherapy | 10 (20) | Â | Â |
+ Surgery | 2 (4) | Â | Â |
+ Radiotherapy + Surgery | 1 (1) | Â | Â |